1, said CEO John Jacobs. Earlier this month ... 2 strain for 2024-25 COVID-19 vaccines. Novavax's traditional protein-based shot offers an alternative vaccine technology to those that are based ...

It's the second straight year that rivals Moderna and Pfizer have gotten a head start in the race to roll out fall vaccines. Novavax Inc. is once again lagging behind rivals Pfizer Inc. and ...

1, said CEO John Jacobs. JN.1 was the dominant strain ... 2 strain for 2024-25 COVID-19 vaccines. Novavax's traditional protein-based shot offers an alternative vaccine technology to those that ...

The newly approved vaccine targets multiple circulating variants, promising enhanced protection and availability across ...

Novavax, Inc. (Nasdaq: NVAX), a global company advancing protein-based vaccines with its Matrix-M™ adjuvant, today announced that doses of the Novavax COVID-19 Vaccine, Adjuvanted (2024-2025 ...

Health Canada authorized Novavax’s updated COVID-19 vaccine that protects against currently circulating variants of the virus on Thursday. The protein-based vaccine, called Nuvaxovid ...

Nike said Thursday that former senior executive Elliott Hill will rejoin the company to succeed John Donahoe as president and CEO, as the sportswear giant shakes up its top rank amid efforts to ...

1, said CEO John Jacobs. Earlier this month ... 2 strain for 2024-25 COVID-19 vaccines. Novavax’s traditional protein-based shot offers an alternative vaccine technology to those that are ...

The U.S. Food and Drug Administration on Friday granted emergency use authorization for an updated version of Novavax's COVID shot. The updated vaccine is authorized for use in individuals 12 years of ...